About Orexo
We start by matching unmet patient needs with the unrealized potential in many existing compounds.
We create novel pharmaceuticals, at lower development cost and risk, with shorter time to market.
The right time for a great concept
What if it were possible to take good drugs with high commercial value and make them even better? Not just through minor reformulations or patent extensions, but by adding innovative properties that really benefit patients? This is precisely what a Swedish physician and his colleagues asked themselves in 1995 when they founded Orexo.
Since then, Orexo has become a progressive, fast-growing pharmaceutical company. We’re product-focused, not platform-driven, and we have a proven track record.
Our approach is to develop proprietary pharmaceuticals to address areas of unmet therapeutic need. We do this by using a stepwise synergy process: First we assess areas of need. Then we work to meet the need by combining existing substances with our proprietary drug delivery technologies and unique expertise in dry pharmaceutical formulations.
- Focus : Manufacturer
- Industry : Pharma
